SRBCF
Price:
$0.0399
Market Cap:
$14.46M
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects include the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. Sirona Biochem Corp. has a research collaboration agreement with the International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop antiviral library of compounds. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. The company was incorporated in 2006 an...[Read more]
Industry
Biotechnology
IPO Date
2013-02-12
Stock Exchange
PNK
Ticker
SRBCF
According to Sirona Biochem Corp.’s latest financial reports and current stock price. The company's current ROE is 90.17%. This represents a change of 298.28% compared to the average of 22.64% of the last 4 quarters.
The mean historical ROE of Sirona Biochem Corp. over the last ten years is -837.30%. The current 90.17% ROE has changed -110.77% with respect to the historical average. Over the past ten years (40 quarters), SRBCF's ROE was at its highest in in the July 2017 quarter at 441.85%. The ROE was at its lowest in in the October 2020 quarter at -858.99%.
Average
-837.30%
Median
-170.66%
Minimum
-8721.86%
Maximum
2.38%
Discovering the peaks and valleys of Sirona Biochem Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.10%
Maximum Annual ROE = 2.38%
Minimum Annual Increase = -468.98%
Minimum Annual ROE = -8721.86%
Year | ROE | Change |
---|---|---|
2023 | 101.27% | -106.11% |
2022 | -1658.53% | -169.77% |
2021 | 2.38% | -127.26% |
2020 | -8721.86% | 4.10% |
2019 | -207.79% | -468.98% |
2018 | 56.31% | -74.24% |
2017 | 218.58% | -214.86% |
2016 | -190.30% | 26.01% |
2015 | -151.02% | -23.31% |
2014 | -196.93% | 58.37% |
The current ROE of Sirona Biochem Corp. (SRBCF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
273.34%
5-year avg
-1621.92%
10-year avg
-837.30%
Sirona Biochem Corp.’s ROE is less than Adynxx, Inc. (0%), greater than NLS Pharmaceutics AG (0%), less than Ascletis Pharma Inc. (22.54%), greater than Surrozen, Inc. (-0.89%), greater than Bolt Biotherapeutics, Inc. (-178.66%), greater than Larimar Therapeutics, Inc. (-61.40%), greater than Keros Therapeutics, Inc. (-35.87%), greater than Kezar Life Sciences, Inc. (-44.73%), greater than Coya Therapeutics, Inc. (-54.50%), greater than Cue Biopharma, Inc. (-35.58%), greater than Lantern Pharma Inc. (-142.93%), greater than Fennec Pharmaceuticals Inc. (-46.39%), greater than Eliem Therapeutics, Inc. (-52.10%), greater than SciSparc Ltd. (-47.03%), greater than OncoSec Medical Incorporated (-87.48%), less than Virax Biolabs Group Limited (484.53%), greater than Hillstream BioPharma, Inc. (-115.10%), greater than ZyVersa Therapeutics, Inc. (-47249.59%), greater than Eiger BioPharmaceuticals, Inc. (-172.51%), greater than Spruce Biosciences, Inc. (-869.84%), greater than Werewolf Therapeutics, Inc. (-59.94%), greater than Unicycive Therapeutics, Inc. (-48.25%), less than Fusion Pharmaceuticals Inc. (294.74%), greater than null (-48.74%),
Company | ROE | Market cap |
---|---|---|
0% | $581.00 | |
0% | $7.33M | |
22.54% | $154.30M | |
-0.89% | $38.09M | |
-178.66% | $25.56M | |
-61.40% | $483.02M | |
-35.87% | $2.25B | |
-44.73% | $51.73M | |
-54.50% | $104.27M | |
-35.58% | $89.71M | |
-142.93% | $35.31M | |
-46.39% | $127.22M | |
-52.10% | $342.68M | |
-47.03% | $2.31M | |
-87.48% | $1.65M | |
484.53% | $8.86M | |
-115.10% | $4.17M | |
-47249.59% | $1.96M | |
-172.51% | $2.55M | |
-869.84% | $22.10M | |
-59.94% | $98.77M | |
-48.25% | $45.28M | |
294.74% | $1.83B | |
-48.74% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sirona Biochem Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sirona Biochem Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Sirona Biochem Corp.'s ROE?
How is the ROE calculated for Sirona Biochem Corp. (SRBCF)?
What is the highest ROE for Sirona Biochem Corp. (SRBCF)?
What is the 3-year average ROE for Sirona Biochem Corp. (SRBCF)?
What is the 5-year average ROE for Sirona Biochem Corp. (SRBCF)?
How does the current ROE for Sirona Biochem Corp. (SRBCF) compare to its historical average?